| Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020 | 525 | 2020 |
| Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet Neurology 20 (9), 739-752, 2021 | 252 | 2021 |
| Furoxans (1,2,5-Oxadiazole-N-Oxides) as Novel NO Mimetic Neuroprotective and Procognitive Agents IT Schiefer, L VandeVrede, M Fa’, O Arancio, GRJ Thatcher Journal of medicinal chemistry 55 (7), 3076-3087, 2012 | 100 | 2012 |
| Benzothiophene selective estrogen receptor modulators provide neuroprotection by a novel GPR30-dependent mechanism R Abdelhamid, J Luo, L VandeVrede, I Kundu, B Michalsen, VA Litosh, ... ACS chemical neuroscience 2 (5), 256-268, 2011 | 89 | 2011 |
| Targeting tau: Clinical trials and novel therapeutic approaches L VandeVrede, AL Boxer, M Polydoro Neuroscience letters 731, 134919, 2020 | 75 | 2020 |
| Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and … EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nat Med 26 (3), 387-397, 2020 | 69 | 2020 |
| Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab L VandeVrede, DM Gibbs, M Koestler, R La Joie, PA Ljubenkov, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 69 | 2020 |
| Seven new species and a new subgenus of forest mice (Rodentia: Muridae: Apomys) from Luzon Island LR Heaney, DS Balete, EA Rickart, PA Alviola, MRM Duya, MV Duya, ... Fieldiana Life and Earth Sciences 2011 (2), 1-60, 2011 | 62 | 2011 |
| Tau positron emission tomographic findings in a former US football player with pathologically confirmed chronic traumatic encephalopathy WG Mantyh, S Spina, A Lee, L Iaccarino, D Soleimani-Meigooni, E Tsoy, ... JAMA neurology 77 (4), 517-521, 2020 | 48 | 2020 |
| Open‐label phase 1 futility studies of salsalate and young plasma in progressive supranuclear palsy L VandeVrede, ML Dale, S Fields, M Frank, E Hare, HW Heuer, K Keith, ... Movement disorders clinical practice 7 (4), 440-447, 2020 | 45 | 2020 |
| Temporal order of clinical and biomarker changes in familial frontotemporal dementia AM Staffaroni, M Quintana, B Wendelberger, HW Heuer, LL Russell, ... Nature medicine 28 (10), 2194-2206, 2022 | 43 | 2022 |
| CSF tau microtubule-binding region identifies pathological changes in primary tauopathies K Horie, NR Barthélemy, S Spina, L VandeVrede, Y He, RW Paterson, ... Nature medicine 28 (12), 2547-2554, 2022 | 41 | 2022 |
| Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy Z Qin, J Luo, L VandeVrede, E Tavassoli, M Fa’, AF Teich, O Arancio, ... Journal of medicinal chemistry 55 (15), 6784-6801, 2012 | 41 | 2012 |
| A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease J Luo, SH Lee, L VandeVrede, Z Qin, M Ben Aissa, J Larson, AF Teich, ... Molecular Neurodegeneration 11, 1-14, 2016 | 40 | 2016 |
| Best practices in the clinical management of progressive supranuclear palsy and corticobasal syndrome: a consensus statement of the CurePSP Centers of Care B Bluett, AY Pantelyat, I Litvan, F Ali, D Apetauerova, D Bega, L Bloom, ... Frontiers in Neurology 12, 694872, 2021 | 39 | 2021 |
| Four-repeat tauopathies: current management and future treatments L VandeVrede, PA Ljubenkov, JC Rojas, AE Welch, AL Boxer Neurotherapeutics 17 (4), 1563-1581, 2020 | 39 | 2020 |
| Advancing Research and Treatment for Frontotemporal Lobar Degeneration investigators. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer’s … EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... Lancet Neurol 20 (9), 739-752, 2021 | 33 | 2021 |
| Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders TF Gendron, MG Heckman, LJ White, AM Veire, O Pedraza, AR Burch, ... Cell Reports Medicine 3 (4), 2022 | 29 | 2022 |
| Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABAA receptor potentiation L VandeVrede, E Tavassoli, J Luo, Z Qin, L Yue, DR Pepperberg, ... British Journal of Pharmacology 171 (2), 389-402, 2014 | 24 | 2014 |
| Multi-modal biomarkers of repetitive head impacts and traumatic encephalopathy syndrome: A clinicopathological case series BM Asken, JA Tanner, L VandeVrede, KB Casaletto, AM Staffaroni, ... Journal of Neurotrauma 39 (17-18), 1195-1213, 2022 | 23 | 2022 |
